Blood Cancer UK
We research, we support, we care. Because it’s time to beat leukaemia, lymphoma, myeloma and all types of blood cancer.
How can we help?
Get involved
Latest news and stories
Our new research strategy
We've launched a new research strategy, outlining our areas of investment for the next five years.
Our response to the 10 Year Health Plan
The government has launched a 10 year health plan - read what our CEO has to say about what this means for our blood cancer community.
Rare blood cancer drug is approved for use
Zanubrutinib (Brukinsa®) is approved as a treatment option for relapsed or refractory mantle cell lymphoma (MCL) in those who have received at least one prior therapy.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox.
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.